FDA Approves XEOMIN® (incobotulinumtoxinA) for Adult Patients with Sialorrhea
Tucson News Now,
Merz North America announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics…
FDA Approves XEOMIN® (incobotulinumtoxinA) for Adult Patients with Sialorrhea
Benzinga,
First and only neurotoxin approved for this indication in the United States Merz North America announced today that the U.S.
FDA Approves XEOMIN® (incobotulinumtoxinA) for Adult Patients with Sialorrhea
Business Wire,
RALEIGH, N.C.--(BUSINESS WIRE)--Merz North America announced today that the U.S.
FDA Approves XEOMIN® (incobotulinumtoxinA) for Adult Patients with Sialorrhea - Press Release
Digital Journal,
RALEIGH, N.C.--(Business Wire)--Merz North America announced today that the U.S.